CASI Pharmaceuticals

CASI

Market cap $27.6M

Overview Fund Trends Analyst Outlook Journalist POV

1.78 USD

+0.04

2.3%

At close Updated Oct 20, 4:00 PM EDT

1 day

2.3%

5 days

2.3%

1 month

6.59%

3 months

45.9%

6 months

-7.29%

Year to date

-40.27%

1 year

-67.64%

5 years

-88.94%

10 years

-87.81%

About: CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Employees: 233

Healthcare Biotechnology